FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Junichiro James Kazama

Research Profile

Procedures

Renal Dialysis

Disorders

Chemicals & Drugs

Geographic Areas

Japan

Anatomy

Bone and Bones

Concepts & Ideas

Co-author Network

Publications

TOP 3
Minako Wakasugi; Kunitoshi Iseki; Junichiro James Kazama; Masatomo Taniguchi; Yoshiharu Tsubakihara; Atsushi Wada; Ichiei Narita
Increased risk of hip fracture among Japanese hemodialysis patients.
Junichiro James Kazama
[Bone metabolism and vascular calcification].
Shigeru Nakai; Hidetomo Nakamoto; Hiroshi Nishi; Satoshi Ogata; Takashi Shigematsu; Toshio Shinoda; Tetsuo Shoji; Kazuyuki Suzuki; Masatomo Taniguchi; Naohiko Fujii; Takayuki Hamano; Norio Hanafusa; Takeshi Hasegawa; Seiji Hashimoto; Kunitoshi Iseki; Noritomo Itami; Junichiro James Kazama; Naoki Kimata; Seiji Marubayashi; Ikuto Masakane; Osamu Morita; Kenji Tsuchida; Atsushi Wada; Kenji Wakai; Yuzo Watanabe; Kunihiro Yamagata; Yoshiharu Tsubakihara
An overview of regular dialysis treatment in Japan (as of 31 December 2010).

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Junichiro James Kazama (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Minako Wakasugi; Kunitoshi Iseki; Junichiro James Kazama; Masatomo Taniguchi; Yoshiharu Tsubakihara; Atsushi Wada; Ichiei Narita
Increased risk of hip fracture among Japanese hemodialysis patients.
Journal of bone and mineral metabolism 2013;31(3):315-21.
2013: Junichiro James Kazama
[Bone metabolism and vascular calcification].
Clinical calcium 2013;23(2):189-94.
2012: Shigeru Nakai; Hidetomo Nakamoto; Hiroshi Nishi; Satoshi Ogata; Takashi Shigematsu; Toshio Shinoda; Tetsuo Shoji; Kazuyuki Suzuki; Masatomo Taniguchi; Naohiko Fujii; Takayuki Hamano; Norio Hanafusa; Takeshi Hasegawa; Seiji Hashimoto; Kunitoshi Iseki; Noritomo Itami; Junichiro James Kazama; Naoki Kimata; Seiji Marubayashi; Ikuto Masakane; Osamu Morita; Kenji Tsuchida; Atsushi Wada; Kenji Wakai; Yuzo Watanabe; Kunihiro Yamagata; Yoshiharu Tsubakihara
An overview of regular dialysis treatment in Japan (as of 31 December 2010).
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2012;16(6):483-521.
2012: Minako Wakasugi; Junichiro James Kazama; Ichiei Narita
Differences in the local and national prevalences of chronic kidney disease based on annual health check program data.
Clinical and experimental nephrology 2012;16(5):749-54.
2012: Suguru Yamamoto; Junichiro James Kazama; Ichiei Narita
[Kidney and bone update : the 5-year history and future of CKD-MBD. Treatment for dialysis-related amyloidosis update].
Clinical calcium 2012;22(7):1089-98.
2012: Minako Wakasugi; Suguru Yamamoto; Kazuko Kawamura; Junichiro James Kazama; Ichiei Narita
High mortality rate of infectious diseases in dialysis patients: a comparison with the general population in Japan.
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2012;16(3):226-31.
2012: Minako Wakasugi; Junichiro James Kazama; Ichiei Narita
Use of Japanese Society for Dialysis Therapy dialysis tables to compare the local and national incidence of dialysis.
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2012;16(1):63-7.
2012: Shigeru Nakai; Hidetomo Nakamoto; Hiroshi Nishi; Satoshi Ogata; Takashi Shigematsu; Toshio Shinoda; Tetsuo Shoji; Kazuyuki Suzuki; Masatomo Taniguchi; Naohiko Fujii; Takayuki Hamano; Norio Hanafusa; Takeshi Hasegawa; Seiji Hashimoto; Kunitoshi Iseki; Noritomo Itami; Junichiro James Kazama; Naoki Kimata; Seiji Marubayashi; Ikuto Masakane; Osamu Morita; Kenji Tsuchida; Atsushi Wada; Kenji Wakai; Yuzo Watanabe; Kunihiro Yamagata; Yoshiharu Tsubakihara
Overview of regular dialysis treatment in Japan (as of 31 December 2009).
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2012;16(1):11-53.
2011: Wataru Mitsuma; Satomi Ohashi; Hiroshi Oya; Naoki Saito; Nobuo Sato; Hiroki Takano; Makoto Tomita; Hiroshi Endoh; Tadayuki Honda; Masahiro Ito; Junichiro James Kazama; Hidenori Kinoshita; Makoto Kodama; Yoshifusa Aizawa
Clinical and cardiac features of patients with subarachnoid haemorrhage presenting with out-of-hospital cardiac arrest.
Resuscitation 2011;82(10):1294-7.
2011: Masatomo Taniguchi; Motoko Tanaka; Takayuki Hamano; Shohei Nakanishi; Hideki Fujii; Hitoshi Kato; Fumihiko Koiwa; Ryoichi Ando; Naoki Kimata; Takashi Akiba; Takashi Kono; Keitaro Yokoyama; Takashi Shigematsu; Takatoshi Kakuta; Junichiro James Kazama; Yoshihiro Tominaga; Masafumi Fukagawa
Comparison between whole and intact parathyroid hormone assays.
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2011;15 Suppl 1():42-9.
2011: Junichiro James Kazama
Bone histology in chronic kidney disease-related mineral and bone disorder.
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2011;15 Suppl 1():23-5.
2011: Junichiro James Kazama; Suguru Yamamoto; Ichiei Narita; Satoshi Kurihara
Nuclear chromatin-concentrated osteoblasts in renal bone diseases.
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2011;15 Suppl 1():9-13.
2011: Yoshiko Iwasaki; Junichiro James Kazama; Hideyuki Yamato; Masafumi Fukagawa
Changes in chemical composition of cortical bone associated with bone fragility in rat model with chronic kidney disease.
Bone 2011;48(6):1260-7.
2011: Junichiro James Kazama; Ichiei Narita
Earthquake in Japan.
Lancet 2011;377(9778):1652-3.
2010: Naoki Takahashi; Hideki Kimura; Kenji Kasuno; Haruyoshi Yoshida; Junichiro James Kazama
[Osteoprotegerin (OPG)].
Nihon rinsho. Japanese journal of clinical medicine 2010;68 Suppl 7():152-5.
2010: Junichiro James Kazama
[CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). Bone metabolism in CKD-MBD].
Clinical calcium 2010;20(7):1038-44.
2010: Junichiro James Kazama; Takashi Yamamoto; Hiroshi Oya; Satoshi Yamamoto; Yoshinobu Sato; Junko Sakurada; Tadayuki Honda; Hiroshi Endoh; Ichiei Narita
A patient with severe hypercalcemia in multiple organ dysfunction syndrome: role of elevated circulating 1alpha,25(OH)2 vitamin D levels.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2010;25(6):1455-9.
2010: Junichiro James Kazama; Ryo Koda; Suguru Yamamoto; Ichiei Narita; Fumitake Gejyo; Akihide Tokumoto
Cancellous bone volume is an indicator for trabecular bone connectivity in dialysis patients.
Clinical journal of the American Society of Nephrology : CJASN 2010;5(2):292-8.
2009: Junichiro James Kazama
Oral phosphate binders: history and prospects.
Bone 2009;45 Suppl 1():S8-12.
2009: Suguru Yamamoto; Junichiro James Kazama; Ichiei Narita; Hironobu Naiki; Fumitake Gejyo
Recent progress in understanding dialysis-related amyloidosis.
Bone 2009;45 Suppl 1():S39-42.
2009: Ryo Koda; Hajime Yamazaki; Junichiro James Kazama; Tomoyuki Ito; Takako Saeki; Iwao Emura; Syoji Miyamura; Ichiei Narita; Fumitake Gejyo
A case report of severe visceral beta2-microglobulin-derived amyloidosis without obvious joint symptoms or radiological findings in a chronic hemodialyzed patient with systemic lupus erythematosus.
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2009;13(3):232-7.
2009: Junichiro James Kazama
[Is lanthanum carbonate a safe drug?].
Clinical calcium 2009;19(2):224-8.
2009: Junichiro James Kazama; Sakumi Kazama; Ryo Koda; Suguru Yamamoto; Ichiei Narita; Fumitake Gejyo
The risk of gallbladder stone formation is increased in patients with predialysis chronic kidney disease but not those undergoing chronic hemodialysis therapy.
Nephron. Clinical practice 2009;111(3):c167-72.
2009: Kazutoshi Nakamura; Junichiro James Kazama; Yoshifumi Tanaka; Keiko Makabe; Mari Oyama; Yasuo Tsuchiya; Masaharu Yamamoto
Microscopic hematuria is associated with low bone mineral density in aged women and men.
Journal of bone and mineral metabolism 2009;27(2):251-4.
2009: Junichiro James Kazama; Ryo Koda; Suguru Yamamoto; Ichiei Narita; Fumitake Gejyo; Akihide Tokumoto
Comparison of quantitative cancellous bone connectivity analyses at two- and three-dimensional levels in dialysis patients.
Calcified tissue international 2009;84(1):38-44.
2008: S Yamamoto; Junichiro James Kazama; Hiroki Maruyama; Shinichi Nishi; Ichiei Narita; Fumitake Gejyo
Patients undergoing dialysis therapy for 30 years or more survive with serious osteoarticular disorders.
Clinical nephrology 2008;70(6):496-502.
2008: Hiroe Sato; Junichiro James Kazama; Takeshi Kuroda; Ichiei Narita; Masaaki Nakano; Fumitake Gejyo
Serum cystatin C measured by a sol particle homogeneous immunoassay can accurately detect early impairment of renal function.
Clinical and experimental nephrology 2008;12(4):270-6.
2008: Kiyoko Hosaka; Junichiro James Kazama; Suguru Yamamoto; Yumi Ito; Noriaki Iino; Hiroki Maruyama; Akihiko Saito; Ichiei Narita; Fumitake Gejyo
Alterations in serum phosphate levels predict the long-term response to intravenous calcitriol therapy in dialysis patients with secondary hyperparathyroidism.
Journal of bone and mineral metabolism 2008;26(2):185-90.
2008: Junichiro James Kazama
[Basic and clinical aspects of calcimimetics. The JSDT guideline and cinacalcet hydrochloride].
Clinical calcium 2008;18(1):27-30.
2007: Junichiro James Kazama
What does the circulating AHSG/fetuin-A level tell us?
Clinical and experimental nephrology 2007;11(4):336-7.
2007: Junichiro James Kazama
Japanese Society of Dialysis Therapy treatment guidelines for secondary hyperparathyroidism.
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2007;11 Suppl 1():S44-7.
2007: Masafumi Fukagawa; Junichiro James Kazama
The making of a bone in blood vessels: from the soft shell to the hard bone.
Kidney international 2007;72(5):533-4.
2007: Junya Ajiro; Bassam Alchi; Ichiei Narita; Kentaro Omori; Daisuke Kondo; Minoru Sakatsume; Junichiro James Kazama; Kohei Akazawa; Fumitake Gejyo
Mortality predictors after 10 years of dialysis: a prospective study of Japanese hemodialysis patients.
Clinical journal of the American Society of Nephrology : CJASN 2007;2(4):653-60.
2007: Hiroyuki Yamashita; Yuji Yamazaki; Hisashi Hasegawa; Takeyoshi Yamashita; Seiji Fukumoto; Takashi Shigematsu; Junichiro James Kazama; Masafumi Fukagawa; Shiro Noguchi
Fibroblast growth factor-23 (FGF23) in patients with transient hypoparathyroidism: its important role in serum phosphate regulation.
Endocrine journal 2007;54(3):465-70.
2007: Suguru Yamamoto; Junichiro James Kazama
[Mechanism of beta(2)-microglobulin-related amyloid fibril formation in CKD].
Clinical calcium 2007;17(5):740-4.
2007: Hiroe Sato; Junichiro James Kazama; Yoko Wada; Takeshi Kuroda; Ichiei Narita; Fumitake Gejyo; Ping Gao; Hiroyuki Yamashita
Decreased levels of circulating alpha2-Heremans-Schmid glycoprotein/Fetuin-A (AHSG) in patients with rheumatoid arthritis.
Internal medicine (Tokyo, Japan) 2007;46(20):1685-91.
2006: Masafumi Fukagawa; Junichiro James Kazama
FGF23: its role in renal bone disease.
Pediatric nephrology (Berlin, Germany) 2006;21(12):1802-6.
2006: Mikio Sugano; Hideyuki Yamato; Tsutomu Hayashi; Hiromi Ochiai; Junji Kakuchi; Sumie Goto; Fuyuhiko Nishijima; Noriaki Iino; Junichiro James Kazama; Tsukasa Takeuchi; Osamu Mokuda; Toshio Ishikawa; Ryo Okazaki
High-fat diet in low-dose-streptozotocin-treated heminephrectomized rats induces all features of human type 2 diabetic nephropathy: a new rat model of diabetic nephropathy.
Nutrition, metabolism, and cardiovascular diseases : NMCD 2006;16(7):477-84.
2006: Masafumi Fukagawa; Shohei Nakanishi; Junichiro James Kazama
Basic and clinical aspects of parathyroid hyperplasia in chronic kidney disease.
Kidney international. Supplement 2006;(102):S3-7.
2006: Yoshihiro Tominaga; Junichiro James Kazama; Hideki Tahara; Masanori Tokumoto
[Early administration of vitamin D and maintenance therapy of secondary hyperparathyroidism: discussion].
Clinical calcium 2006;16(6):1043-52.
2006: Junichiro James Kazama; Kentaro Omori; Suguru Yamamoto; Yumi Ito; Hiroki Maruyama; Ichiei Narita; Fumitake Gejyo; Yoshiko Iwasaki; Masafumi Fukagawa
Circulating osteoprotegerin affects bone metabolism in dialysis patients with mild secondary hyperparathyroidism.
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2006;10(3):262-6.
2006: Ichiei Narita; Bassam Alchi; Kentaro Omori; Fuminori Sato; Junya Ajiro; Daisuke Saga; Daisuke Kondo; M Skatsume; S Maruyama; Junichiro James Kazama; Kohei Akazawa; Fumitake Gejyo
Etiology and prognostic significance of severe uremic pruritus in chronic hemodialysis patients.
Kidney international 2006;69(9):1626-32.
2006: Sachiko Fukase; Junichiro James Kazama; Honami Mori; Seitaro Iguchi; Tetsuro Takeda; Mitsuhiro Ueno; Shinichi Nishi; Ichiei Narita; Fumitake Gejyo
Para-capillary electron-dense deposits reduce glomerular filtration in patients with primary glomerular diseases.
Clinical and experimental nephrology 2006;10(1):33-9.
2006: Junichiro James Kazama; Suguru Yamamoto; Naoki Takahashi; Yumi Ito; Hiroki Maruyama; Ichiei Narita; Fumitake Gejyo
Abeta-2M-amyloidosis and related bone diseases.
Journal of bone and mineral metabolism 2006;24(2):182-4.
2005: Junichiro James Kazama; Masafumi Fukagawa
[Chronic renal failure].
Nihon rinsho. Japanese journal of clinical medicine 2005;63 Suppl 10():226-8.
2005: Hiroyuki Yamashita; Shiro Noguchi; Yuji Yamasaki; Hisashi Hasegawa; Takeyoshi Yamashita; Seiji Fukumoto; Takashi Shigematsu; Junichiro James Kazama; Masafumi Fukagawa
[Fibroblast growth factor (FGF)-23 in patients with hypoparathyroidism].
Clinical calcium 2005;15 Suppl 1():41-5; discussion 45.
2005: Junichiro James Kazama; Hiroki Maruyama; Ichiei Narita; Fumitake Gejyo
Maxacalcitol is a possible less phosphatemic vitamin D analog.
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2005;9(4):352-4.
2005: Fumihiko Koiwa; Junichiro James Kazama; Akihide Tokumoto; Noritaka Onoda; Hitoshi Kato; Tomoyuki Okada; Tomoko Nii-Kono; Masafumi Fukagawa; Takashi Shigematsu
Sevelamer hydrochloride and calcium bicarbonate reduce serum fibroblast growth factor 23 levels in dialysis patients.
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2005;9(4):336-9.
2005: Junichiro James Kazama; Fumitake Gejyo; Takashi Shigematsu; Masafumi Fukagawa
Role of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism.
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2005;9(4):328-30.
2005: Junichiro James Kazama; Kentaro Omori; N Takahashi; Yumi Ito; Hiroki Maruyama; Ichiei Narita; Fumitake Gejyo; Y Iwasaki; Masafumi Fukagawa
Maxacalcitol therapy decreases circulating osteoprotegerin levels in dialysis patients with secondary hyperparathyroidism.
Clinical nephrology 2005;64(1):64-8.
2005: Masafumi Fukagawa; Tomoko Nii-Kono; Junichiro James Kazama
Role of fibroblast growth factor 23 in health and in chronic kidney disease.
Current opinion in nephrology and hypertension 2005;14(4):325-9.
2005: Masafumi Fukagawa; Junichiro James Kazama
With or without the kidney: the role of FGF23 in CKD.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2005;20(7):1295-8.
2005: Hiroyuki Yamashita; Yuji Yamazaki; Hisashi Hasegawa; Takeyoshi Yamashita; Seiji Fukumoto; Takashi Shigematsu; Junichiro James Kazama; Masafumi Fukagawa; Shiro Noguchi
Fibroblast growth factor-23 in patients with Graves' disease before and after antithyroid therapy: its important role in serum phosphate regulation.
The Journal of clinical endocrinology and metabolism 2005;90(7):4211-5.
2005: Yuko Oyama; Junichiro James Kazama; Kentaro Omori; Noboru Higuchi; Shigemi Kameda; Suguru Yamamoto; Yumi Ito; Hiroki Maruyama; Ichiei Narita; Fumitake Gejyo
Pretreatment plasma intact parathyroid hormone and serum calcium levels, but not serum phosphate levels, predict the response to maxacalcitol therapy in dialysis patients with secondary hyperparathyroidism.
Clinical and experimental nephrology 2005;9(2):142-7.
2005: Junichiro James Kazama; Fumitake Gejyo; Isei Ei
The immunohistochemical localization of alpha2-Heremans-Schmid glycoprotein/fetuin-A (AHSG).
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2005;20(4):851-2.
2005: Yuko Oyama; Tetsuro Takeda; Hitomi Hama; Atsuhito Tanuma; Noriaki Iino; Kiyoko Sato; Ryohei Kaseda; Meilei Ma; Tadashi Yamamoto; Hiroshi Fujii; Junichiro James Kazama; Shoji Odani; Yoshio Terada; Kunihiro Mizuta; Fumitake Gejyo; Akihiko Saito
Evidence for megalin-mediated proximal tubular uptake of L-FABP, a carrier of potentially nephrotoxic molecules.
Laboratory investigation; a journal of technical methods and pathology 2005;85(4):522-31.
2005: Shohei Nakanishi; Junichiro James Kazama; Tomoko Nii-Kono; Kentaro Omori; Takeyoshi Yamashita; Seiji Fukumoto; Fumitake Gejyo; Takashi Shigematsu; Masafumi Fukagawa
Serum fibroblast growth factor-23 levels predict the future refractory hyperparathyroidism in dialysis patients.
Kidney international 2005;67(3):1171-8.
2005: Junichiro James Kazama; Fuminori Sato; Kentaro Omori; Hitomi Hama; Suguru Yamamoto; Hiroki Maruyama; Ichiei Narita; Fumitake Gejyo; Takeyoshi Yamashita; Seiji Fukumoto; Masafumi Fukagawa
Pretreatment serum FGF-23 levels predict the efficacy of calcitriol therapy in dialysis patients.
Kidney international 2005;67(3):1120-5.
2005: Junichiro James Kazama; Suguru Yamamoto; Shigemi Kameda; Hiroki Maruyama; Ichiei Narita; Takashi Shigematsu; Fumitake Gejyo
Direct comparison between two 1-84PTH assays in dialysis patients.
Nephron. Clinical practice 2005;99(1):c8-12.
2004: Junichiro James Kazama
[Direct effects of vitamin D on bone].
Clinical calcium 2004;14(9):27-30.
2004: Tetsuhiko Sato; Yoshihiro Tominaga; Tsuneo Ueki; Norihiko Goto; Susumu Matsuoka; Akio Katayama; Toshihito Haba; Kazuharu Uchida; Shohei Nakanishi; Junichiro James Kazama; Fumitake Gejyo; Takeyoshi Yamashita; Masafumi Fukagawa
Total parathyroidectomy reduces elevated circulating fibroblast growth factor 23 in advanced secondary hyperparathyroidism.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2004;44(3):481-7.
2004: Shin-ichi Kinebuchi; Junichiro James Kazama; Makoto Satoh; Kunihiko Sakai; Hideaki Nakayama; Hirohisa Yoshizawa; Ichiei Narita; Eiichi Suzuki; Fumitake Gejyo
Short-term use of continuous positive airway pressure ameliorates glomerular hyperfiltration in patients with obstructive sleep apnoea syndrome.
Clinical science (London, England : 1979) 2004;107(3):317-22.
2004: Takashi Shigematsu; Junichiro James Kazama; Takeyoshi Yamashita; Seiji Fukumoto; Tatsuo Hosoya; Fumitake Gejyo; Masafumi Fukagawa
Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2004;44(2):250-6.
2004: Hitomi Hama; Akihiko Saito; Tetsuro Takeda; Atsuhito Tanuma; Yuansheng Xie; Kiyoko Sato; Junichiro James Kazama; Fumitake Gejyo
Evidence indicating that renal tubular metabolism of leptin is mediated by megalin but not by the leptin receptors.
Endocrinology 2004;145(8):3935-40.
2004: Hiroyuki Yamashita; Takeyoshi Yamashita; Masashi Miyamoto; Takashi Shigematsu; Junichiro James Kazama; Takashi Shimada; Yuji Yamazaki; Seiji Fukumoto; Masafumi Fukagaw; Shiro Noguchi
Fibroblast growth factor (FGF)-23 in patients with primary hyperparathyroidism.
European journal of endocrinology / European Federation of Endocrine Societies 2004;151(1):55-60.
2004: Junichiro James Kazama
Osteoprotegerin and bone mineral metabolism in renal failure.
Current opinion in nephrology and hypertension 2004;13(4):411-5.
2004: Suguru Yamamoto; Fumitake Gejyo; Junichiro James Kazama
[Prevention of dialysis-related amyloidosis].
Nihon rinsho. Japanese journal of clinical medicine 2004;62 Suppl 6():353-6.
2004: Junichiro James Kazama; Masafumi Fukagawa
[Adynamic bone disease].
Nihon rinsho. Japanese journal of clinical medicine 2004;62 Suppl 6():330-3.
2004: Hiroshi Hayakawa; Takashi Shigematsu; Junichiro James Kazama
[Bone disease in secondary hyperparathyroidism].
Nihon rinsho. Japanese journal of clinical medicine 2004;62 Suppl 6():324-9.
2004: Junichiro James Kazama; Kentaro Omori; Noboru Higuchi; Naoki Takahashi; Yumi Ito; Hiroki Maruyama; Ichiei Narita; Tom Cantor; Ping Gao; Fumitake Gejyo
Intact PTH assay overestimates true 1-84 PTH levels after maxacalcitol therapy in dialysis patients with secondary hyperparathyroidism.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2004;19(4):892-7.
2003: Junichiro James Kazama; K Suzuki; A Yokoseki; Akihisa Oyanagi; S Goto; H Shimada; Hiroki Maruyama; Ichiei Narita; Fumitake Gejyo
Development of hungry bone syndrome after rapid lowering of PTH with intravenous maxacalcitol therapy in a patient with non-uremic secondary hyperparathyroidism.
Clinical nephrology 2003;60(5):369-71.
2003: Masafumi Fukagawa; Yoshiko Iwasaki; Junichiro James Kazama
Skeletal resistance to parathyroid hormone as a background abnormality in uremia.
Nephrology (Carlton, Vic.) 2003;8 Suppl():S50-2.
2003: Hiroshi Kikuchi; Hiroki Maruyama; Saori Omori; Junichiro James Kazama; Fumitake Gejyo
The sequential organ failure assessment score as a useful predictor for estimating the prognosis of systemic inflammatory response syndrome patients being treated with extracorporeal blood purification.
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2003;7(4):456-60.
2003: Akihiko Saito; Junichiro James Kazama; Noriaki Iino; Kenji Cho; Nobuo Sato; Hajime Yamazaki; Yuko Oyama; Tetsuro Takeda; Robert A Orlando; Fujio Shimizu; Yasuhiko Tabata; Fumitake Gejyo
Bioengineered implantation of megalin-expressing cells: a potential intracorporeal therapeutic model for uremic toxin protein clearance in renal failure.
Journal of the American Society of Nephrology : JASN 2003;14(8):2025-32.
2003: Junichiro James Kazama; Tsukasa Omori; Isei Ei; Kyoko Ei; Mizue Oda; Hiroki Maruyama; Ichiei Narita; Fumitake Gejyo; Takashi Shigematsu; Masafumi Fukagawa
Circulating 1-84 PTH and large C-terminal PTH fragment levels in uremia.
Clinical and experimental nephrology 2003;7(2):144-9.
2003: Yuko Oyama; Junichiro James Kazama; Hiroki Maruyama; Ichiei Narita; Chizuko Kanbayashi; Yu Koyama; Tsukasa Omori; Katsuyoshi Hatakeyama; Fumitake Gejyo
Combined radioguided parathyroidectomy and intravenous vitamin D therapy for the treatment of uraemic hyperparathyroidism.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2003;18 Suppl 3():iii76-8.
2003: Junichiro James Kazama
[Renal bone disease and osteoprotegerin].
Clinical calcium 2003;13(3):311-5.
2003: Junichiro James Kazama; N Takahashi; Yumi Ito; Y Watanabe; Noriaki Iino; Seitaro Iguchi; Akihisa Oyanagi; H Obayashi; S Ito; Hiroki Maruyama; Ichiei Narita; S Yamamoto; Y Sato; A Tsuchiya; T Ichida; Fumitake Gejyo
Successful perioperative blood purification therapy in patients with maintenance hemodialysis therapy who underwent living donor liver transplantation.
Clinical nephrology 2003;59(3):229-33.
2003: Junichiro James Kazama; Yoshiko Iwasaki; Hideyuki Yamato; Hisashi Murayama; Masami Sato; Fumitake Gejyo; Masafumi Kurokawa; Kiyoshi Fukagawa
Microfocus computed tomography analysis of early changes in bone microstructure in rats with chronic renal failure.
Nephron. Experimental nephrology 2003;95(4):e152-7.
2002: Junichiro James Kazama
[Pathophysiology and clinical features of adynamic bone disease].
Clinical calcium 2002;12(12):1636-9.
2002: Junichiro James Kazama; Hitoshi Kato; Tetsuhiko Sato; Takashi Shigematsu; Masafumi Fukagawa; Yoshiko Iwasaki; Fumitake Gejyo
Circulating osteoprotegerin is not removed through haemodialysis membrane.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2002;17(10):1860-1.
2002: Kentaro Omori; Junichiro James Kazama; Jin Song; Shin Goto; Toshinori Takada; Noriko Saito; Minoru Sakatsume; Ichiei Narita; Fumitake Gejyo
Association of the MCP-1 gene polymorphism A-2518G with carpal-tunnel syndrome in hemodialysis patients.
Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis 2002;9(3):175-82.
2002: Masafumi Fukagawa; Junichiro James Kazama; Takashi Shigematsu
Management of patients with advanced secondary hyperparathyroidism: the Japanese approach.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2002;17(9):1553-7.
2002: Junichiro James Kazama
[The skeletal resistance to PTH and osteoprotegerin].
Clinical calcium 2002;12(6):764-7.
2002: Takashi Shigematsu; Junichiro James Kazama; Masafumi Hukagawa
[The up-to-date of PTH assay: the progression and some clinical problem].
Clinical calcium 2002;12(6):759-63.
2002: Hiroki Maruyama; Noboru Higuchi; Yuji Nishikawa; Shigemi Kameda; Noriaki Iino; Junichiro James Kazama; N Takahashi; M Sugawa; H Hanawa; N Tada; Jun-Ichi Miyazaki; Fumitake Gejyo
High-level expression of naked DNA delivered to rat liver via tail vein injection.
The journal of gene medicine 2002;4(3):333-41.
2002: Junichiro James Kazama; Keiko Kutsuwada; Ken Ataka; Hiroki Maruyama; Fumitake Gejyo
Serum cystatin C reliably detects renal dysfunction in patients with various renal diseases.
Nephron 2002;91(1):13-20.
2002: Junichiro James Kazama; Takashi Shigematsu; Kazuki Yano; Eisuke Tsuda; Masakazu Miura; Yoshiko Iwasaki; Yoshindo Kawaguchi; Fumitake Gejyo; Kiyoshi Kurokawa; Masafumi Fukagawa
Increased circulating levels of osteoclastogenesis inhibitory factor (osteoprotegerin) in patients with chronic renal failure.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2002;39(3):525-32.
2002: Masafumi Fukagawa; Junichiro James Kazama; Kiyoshi Kurokawa
Renal osteodystrophy and secondary hyperparathyroidism.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2002;17 Suppl 10():2-5.
2002: Kiyoko Sato; Junichiro James Kazama; Yoko Wada; Hiroki Maruyama; Ichiei Narita; Fumitake Gejyo; Kentaro Sugiyama; Hiroshi Satoh
Hypersensitivity to paraoxybenzoic Acid esters (parabens) in a dialysis patient.
Nephron 2002;92(3):728-9.
2001: S Nakanishi; Junichiro James Kazama; Takashi Shigematsu; Yoshiko Iwasaki; Tom Cantor; T Kurosawa; Masafumi Fukagawa
Comparison of intact PTH assay and whole PTH assay in long-term dialysis patients.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2001;38(4 Suppl 1):S172-4.
2001: Masafumi Fukagawa; Junichiro James Kazama; Takashi Shigematsu
Skeletal resistance to pth as a basic abnormality underlying uremic bone diseases.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2001;38(4 Suppl 1):S152-5.
2001: Masafumi Fukagawa; Junichiro James Kazama; Takashi Shigematsu
[PTH and bone metabolism in chronic dialysis patients].
Rinsho byori. The Japanese journal of clinical pathology 2001;49(3):236-8.
2001: Seitaro Iguchi; Shinichi Nishi; J Shinbo; Noriaki Iino; Junichiro James Kazama; H Shimada; M Ueno; K Saitou; T Tanigawa; K Takahashi; F Gejyo
Intratubular calcification in a post-renal transplanted patient with secondary hyperparathyroidism.
Clinical transplantation 2001;15 Suppl 5():51-4.
2001: Junichiro James Kazama; Hiroki Maruyama; Fumitake Gejyo
Reduction of circulating beta2-microglobulin level for the treatment of dialysis-related amyloidosis.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2001;16 Suppl 4():31-5.
2000: Hiroki Maruyama; M Sugawa; Y Moriguchi; Ikuo Imazeki; Y Ishikawa; Ken Ataka; S Hasegawa; Y Ito; Noboru Higuchi; Junichiro James Kazama; Fumitake Gejyo; Jun-Ichi Miyazaki
Continuous erythropoietin delivery by muscle-targeted gene transfer using in vivo electroporation.
Human gene therapy 2000;11(3):429-37.
1998: Junichiro James Kazama; Masaaki Arakawa; Fumitake Gejyo
Synovial inflammatory cells captured 131I-beta 2-microglobulin in patients with dialysis related amyloidosis.
Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis 1998;5(1):24-9.